COVID-19 and Relative Angiotensin-converting Enzyme 2 Deficiency: Role in Disease Severity and Therapeutic Response

Overview

Journal Open Heart

Publisher BMJ Publishing Group

Specialty Cardiology & Vascular Diseases

Date 2020 Jun 14

PMID 32532804

Citations 5

Authors

Paul MacDaragh Ryan

Noel Caplice

Affiliations

Soon will be listed here.

Citing Articles

SARS-CoV-2 presence in recreational seawater and evaluation of intestine permeability: experimental evidence of low impact on public health.

Norese C, Nicosia E, Cortese K, Gentili V, Rizzo R, Rizzo S Front Public Health. 2024; 12:1326453.

PMID: 38500723 PMC: 10944960. DOI: 10.3389/fpubh.2024.1326453.

COVID-19: the possibility, ways, mechanisms, and interruptions of mother-to-child transmission.

Wang J, Dong W Arch Gynecol Obstet. 2022; 307(6):1687-1696.

PMID: 35665849 PMC: 9166277. DOI: 10.1007/s00404-022-06639-5.

Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings.

Fahmy O, Daas F, Salunkhe V, Petrey J, Cosar E, Ramirez J Crit Care Explor. 2021; 3(5):e0427.

PMID: 34036278 PMC: 8140776. DOI: 10.1097/CCE.0000000000000427.

SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges.

Coke C, Davison B, Fields N, Fletcher J, Rollings J, Roberson L J Clin Med. 2021; 10(1).

PMID: 33466289 PMC: 7795434. DOI: 10.3390/jcm10010156.

Pro: Venoarterial ECMO Should Be Considered in Patients With COVID-19.

Bhatia M, Kumar P J Cardiothorac Vasc Anesth. 2020; 35(3):703-706.

PMID: 33288430 PMC: 7672337. DOI: 10.1053/j.jvca.2020.11.027.

References

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Thomas M, Pickering R, Tsorotes D, Koitka A, Sheehy K, Bernardi S . Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res. 2010; 107(7):888-97. DOI: 10.1161/CIRCRESAHA.110.219279. View

Wei C, Tian B, Perry G, Meng Q, Chen Y, Oparil S . Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene. Am J Physiol Heart Circ Physiol. 2002; 282(6):H2254-8. DOI: 10.1152/ajpheart.00191.2001. View

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

Letko M, Marzi A, Munster V . Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020; 5(4):562-569. PMC: 7095430. DOI: 10.1038/s41564-020-0688-y. View

Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S . Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. 2020; 17(6):613-620. PMC: 7091888. DOI: 10.1038/s41423-020-0400-4. View

Coffman T . The inextricable role of the kidney in hypertension. J Clin Invest. 2014; 124(6):2341-7. PMC: 4092877. DOI: 10.1172/JCI72274. View

Gu J, Korteweg C . Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007; 170(4):1136-47. PMC: 1829448. DOI: 10.2353/ajpath.2007.061088. View

10.

Zhang H, Baker A . Recombinant human ACE2: acing out angiotensin II in ARDS therapy. Crit Care. 2017; 21(1):305. PMC: 5729230. DOI: 10.1186/s13054-017-1882-z. View

11.

Wong D, Oudit G, Reich H, Kassiri Z, Zhou J, Liu Q . Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol. 2007; 171(2):438-51. PMC: 1934545. DOI: 10.2353/ajpath.2007.060977. View

12.

Daemen M, Lombardi D, Bosman F, Schwartz S . Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991; 68(2):450-6. DOI: 10.1161/01.res.68.2.450. View

13.

Law A, Lee D, Cheung B, Yim H, Lau A . Role for nonstructural protein 1 of severe acute respiratory syndrome coronavirus in chemokine dysregulation. J Virol. 2006; 81(1):416-22. PMC: 1797241. DOI: 10.1128/JVI.02336-05. View

14.

Tesanovic S, Vinh A, Gaspari T, Casley D, Widdop R . Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2010; 30(8):1606-13. DOI: 10.1161/ATVBAHA.110.204453. View

15.

Lee M, Bohm M, Paul M, Ganten D . Tissue renin-angiotensin systems. Their role in cardiovascular disease. Circulation. 1993; 87(5 Suppl):IV7-13. View

16.

Cheng V, Lau S, Woo P, Yuen K . Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007; 20(4):660-94. PMC: 2176051. DOI: 10.1128/CMR.00023-07. View

17.

Tikellis C, Bialkowski K, Pete J, Sheehy K, Su Q, Johnston C . ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes. 2008; 57(4):1018-25. DOI: 10.2337/db07-1212. View

18.

Dijkman R, Jebbink M, Deijs M, Milewska A, Pyrc K, Buelow E . Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. J Gen Virol. 2012; 93(Pt 9):1924-1929. DOI: 10.1099/vir.0.043919-0. View

19.

Candido R, Jandeleit-Dahm K, Cao Z, Nesteroff S, Burns W, Twigg S . Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation. 2002; 106(2):246-53. DOI: 10.1161/01.cir.0000021122.63813.32. View

20.

Gralinski L, Baric R . Molecular pathology of emerging coronavirus infections. J Pathol. 2014; 235(2):185-95. PMC: 4267971. DOI: 10.1002/path.4454. View